This video is sponsored by the Duke Clinical Medical Series.
Topics include:
* Case Presentation
* ACS in the Era of Gluttony and Sloth: Considering the Metabolic Syndrome
* NCEP ATP III Criteria for Metabolic Syndrome
* Prevalence of Metabolic Syndrome Components: NHANES III
* Obesity Trends Among U.S. Adults: BRFSS in 1985
* Visceral Adiposity: The Heart of the Problem
* Prevalence of Metabolic Syndrome Components: MIRACL Study
* Metabolic Syndrome and CV Risk After ACS
* Overweight and Obesity in ACS: SYMPHONY Studies
* Adjusted Mortality by BMI: Observations from SYMPHONY Studies
The moderator, Kristin Newby, MD, has indicated that she receives research/grant support
from Bristol-Myers Squibb, Sanofi, Millennium Pharmaceuticals, Inc., Schering-Plough
Research Institute, Novartis and Roche Diagnostics Corporation. Dr. Newby is also a member
of an advisory board for Eli Lilly and a consultant for Proctor and Gamble; she has spoken
at scientific symposia for Aventis, Bristol-Myers Squibb, Sanofi and Millennium
Pharmaceuticals, Inc.
The guest faculty, Darren McGuire, MD, has indicated that he receives research/grant
support from GlaxoSmithKline, Pfizer, and Biosite, Inc. He also receives honoraria from
Takeda and Pfizer.
|
|